Explorer les evidences

Plasmodium ovale was sensitive to all tested drugs within the follow-up periods and on interpretable in vitro assays.

Gabonpaludismepublié 2017Malaria journalPubMeddocument de 4 observations

12,9 %70 malaria interventional trials (12.9%) were registered following study completion.

Gabonpaludismeobservé 2010 to 2020publié 2024Malaria journalPubMeddocument de 13 observations

12 %During a period of one year, 12% of the thick blood smears from the 497 afebrile males screened showed Plasmodium falciparum with low parasitemias in villages near Lambaréné, Gabon.

Gabonpaludismeobservé one yearpublié 2007The American journal of tropical medicine and hygieneeurope_pmcdocument de 4 observationsDOI 10.4269/ajtmh.2007.77.939

217 patientsThe study included 217 patients (111 malaria patients and 106 symptomatic controls, defined as malaria-negative febrile patients).

Gabonpaludismepublié 2017The American journal of tropical medicine and hygieneeurope_pmcdocument de 3 observations

5,3 %Sub-microscopic Plasmodium ovale infection had a prevalence of 5.3% among participants.

Gabonpaludismeobservé 2021publié 2022Parasites & vectorseurope_pmcdocument de 7 observations

1,1 %The prevalence of the rdl A269G mutation in Anopheles mosquitoes from the Bijagós Archipelago was 1.1%.

Gabonpaludismeobservé 2019publié 2024Parasites & vectorsPubMeddocument de 6 observations

Females aged ≥ 11 years made significantly higher levels of antibodies to PfCSP than males in most trials.

Gabonpaludismepublié 2022Frontiers in immunologyPubMeddocument de 5 observations

0 per_19No secondary treatment failures occurred in recrudescence cases retreated with AL (0/19).

Gabonpaludismepublié 2025Tropical diseases, travel medicine and vaccinesPubMeddocument de 5 observations

0,02 correlation_coefficientThe correlation between antibodies to the C-terminal region of CSP and RTS,S/AS01 response was r = 0·02 [-0·10 to 0·15].

Gabonpaludismepublié 2025The Lancet. Infectious diseasesPubMeddocument de 11 observations

4,9 odds_ratioDiarrhoea was a risk factor for recrudescence in the cohort, with an unadjusted odds ratio of 4.9 (95% CI: 1.14–21.06).

Gabonpaludismepublié 2025Tropical diseases, travel medicine and vaccinesPubMeddocument de 5 observations

3,1 nMThe mean concentration required to inhibit 50% of growth (IC50) of Plasmodium malariae with atovaquone was 3.1 nM.

Gabonpaludismepublié 2025Pathogens (Basel, Switzerland)europe_pmcdocument de 4 observations

58 %In 2005–07, 58% of the isolates carried the same microsatellite alleles in a chromosomal fragment spanning 39 kb surrounding the pfcrt locus.

Gabonpaludismeobservé 2005 - 07publié 2011Malaria journaleurope_pmcdocument de 4 observationsDOI 10.1186/1475-2875-10-304

95 %In part B, the PCR-corrected adequate clinical and parasitological response at day 29 was 95% (95% CI 83–99) for the 3-day regimen of ganaplacide 400 mg plus lumefantrine-SDF 960 mg in children.

Gabonpaludismepublié 2023The Lancet. Infectious diseasesPubMeddocument de 10 observations

Prevalence of chloroquine-resistant Plasmodium falciparum remains high, especially in rural areas.

Gabonpaludismepublié 2019Malaria journaleurope_pmcdocument de 4 observationsDOI 10.1186/s12936-019-2972-y

39 samplesIC50 was successfully determined in 39 out of 46 samples from malaria patients in Gabon.

Gabonpaludismepublié 2015Malaria journalPubMeddocument de 4 observations

200 000 000 casesMalaria results in more than 200 million clinical cases annually.

Gabonpaludismepublié 2015VaccinePubMeddocument de 2 observations

7 genotypes_per_sampleThe highest combined genotype complexity in samples that contained mixed-species infections was seven.

Gabonpaludismepublié 2017Malaria journaleurope_pmcdocument de 6 observations

Malaria is one of the leading causes of morbidity and mortality in African countries.

Gabonpaludismepublié 2021Malaria journalPubMeddocument de 9 observations

Women with moderate or severe anaemia had higher parasite prevalences and densities.

Gabonanémie · paludismepublié 2003Malaria JournalOpenAlexdocument de 5 observationsDOI 10.1186/1475-2875-2-18

26,1 %The global clinical cases of malaria were 26.1% (658/2015) in Franceville between 2017 and 2019.

Gabonpaludismeobservé 2017-2019publié 2023Journal of public health in Africaeurope_pmcdocument de 7 observationsDOI 10.4081/jphia.2023.1865

7,69 %Among 70 malaria-positive patient samples screened for polymorphism in Libreville, Gabon, the alternative alanine/phenylalanine mutation at SA/F in Pfdhps occurred in 7.69% (n = 5) of samples.

Gabonpaludismepublié 2023Malaria journalPubMeddocument de 11 observations

460 000 cases_per_yearGabon is a high-transmission malaria country with more than 460,000 malaria cases per year.

Gabonpaludismepublié 2021Antimicrobial agents and chemotherapyeurope_pmcdocument de 4 observations

5 participantsTwelve weeks following immunization, 5 out of 5 participants receiving placebo developed parasitemia after controlled human malaria infection (CHMI) using the Pf7G8 strain.

Gabonpaludismepublié 2021Nature communicationsPubMeddocument de 4 observations

31,5 %Malaria prevalence in Franceville was 31.5% in 2021.

Gabonpaludismeobservé 2021publié 2022BMC Public HealthOpenAlexdocument de 8 observationsDOI 10.1186/s12889-022-14765-7

13,3 %Plasmodium spp. was detected in 13.3% of afebrile children (8 out of 60) in Gabon.

Gabonpaludismepublié 2016The American journal of tropical medicine and hygieneeurope_pmcdocument de 9 observations